Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218296 · ClinicalTrials.gov registry record · Phase 2
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 332
- Enrollment target
NCT00218296: Completed Phase 2 study, sponsored by University of Minnesota.
NCT00218296 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 332 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (150% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218296, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 332 participants
- Enrollment target
Study Summary
Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.
Primary Outcome
No tobacco use 7 days prior to Week 12 verified by biomarkers (urine, cotinine and CO)
Interventions
- DRUG Usual Care Group
- OTHER Reduction Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
What the finished NCT00218296 record still lists
NCT00218296 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (150% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care Group is the first listed.
NCT00218296 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218296 about?
NCT00218296 is a clinical study titled "Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use". Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally eff...
What is the current status of trial NCT00218296?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 332 participants. The study started on 2006-11. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00218296?
The interventions under investigation include: Usual Care Group (DRUG), Reduction Group (OTHER).
Who is sponsoring clinical trial NCT00218296?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00218296's enrollment target sits among peer trials
332 144th of 2000 higher than 1,856 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia